Topic List : Immunology
-
Cellular ‘death code’ discovered
Stanford scientists and their collaborators have discovered a molecule that initiates the final, crucial step in a type of cell death.
-
Special diet helps bacteria engraft in gut
Gut bacteria able to digest seaweed can outcompete native bacteria in the large intestine of nori-fed mice, according to Stanford scientists. Favoring one species over others in the gut could help advance precision health.
-
$11.9 million for anti-leukemia trial
The California Institute for Regenerative Medicine awarded Stanford researcher Crystal Mackall a grant to study immune cells genetically modified to attack two proteins on leukemia and lymphoma cells.
-
Older people’s immune cells diverge more
Stanford scientists, focusing on chemical adjuncts affixed to DNA-associated proteins, found that these markings become more diverse with age.
-
Altered immune cells attack brain tumor
In mice, a fatal brainstem tumor was cleared by injecting it with engineered T cells that recognized the cancer and targeted it for destruction. The Stanford discovery is moving to human trials.
-
Conference on human immune monitoring
The two-day event will highlight the latest research by top scientists on technologies and analytic methods geared toward studying human immunology.
-
Antibody treatment for ‘bubble boy’ disease
In a clinical trial, participants were given an antibody to CD117, a cell surface marker, in an effort to wipe out their defective blood stem cells without high-risk chemotherapy or radiation.
-
Schneider on disease and data sculptures
Many infectious diseases, including malaria, are marked by cyclical ups and downs. David Schneider takes a creative approach to making sense of those ups and downs.
-
'Vaccine’ destroys tumors in mice
Activating T cells in tumors eliminated even distant metastases in mice, Stanford researchers found. Lymphoma patients are being recruited to test the technique in a clinical trial.
-
Screen could reveal immunotherapy targets
Stanford scientists have developed a biochemical screen that identifies molecules critical to immunotherapy for a host of diseases, including cancer.